BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32201147)

  • 21. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evidence for laser treatments to the vulvo-vagina: Making sure we do not repeat past mistakes.
    Song S; Budden A; Short A; Nesbitt-Hawes E; Deans R; Abbott J
    Aust N Z J Obstet Gynaecol; 2018 Apr; 58(2):148-162. PubMed ID: 29067688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No. 385-Indications for Pelvic Examination.
    Evans D; Goldstein S; Loewy A; Altman AD
    J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Device-based treatment for vaginal wellness.
    Alexiades M
    Semin Cutan Med Surg; 2018 Dec; 37(4):226-232. PubMed ID: 30475926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Short-term efficacy of vaginal CO
    Kozma B; Póka R; Sipos A; Ács N; Takács P
    Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of vaginal therapies alternative to vaginal estrogens on sexual function and orgasm of menopausal women: A systematic review and meta-analysis of randomized controlled trials.
    Pitsouni E; Grigoriadis T; Douskos A; Kyriakidou M; Falagas ME; Athanasiou S
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():45-56. PubMed ID: 30103082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Light and energy-based therapeutics for genitourinary applications: Consensus on protocols and best practices.
    Alexiades MR; Iglesias C; Sokol E; Gaspar A; Tadir Y
    Lasers Surg Med; 2023 Jul; 55(5):444-454. PubMed ID: 37130435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of laser in urogynaecology.
    Bhide AA; Khullar V; Swift S; Digesu GA
    Int Urogynecol J; 2019 May; 30(5):683-692. PubMed ID: 30564874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genitourinary syndrome of menopause (GSM) and laser VEL: a review.
    Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E
    Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vaginal LASER therapy for genito-urinary disorders: A systematic review and statement from the Committee for Female Urology and Pelviperineology of the French Association of Urology].
    Klap J; Campagne-Loiseau S; Berrogain N; Bosset PO; Cardot V; Charles T; Deffieux X; Donon L; Girard F; Peyrat L; Roulette P; Thuillier C; Tibi B; Vidart A; Wagner L; Hermieu JF; Cornu JN;
    Prog Urol; 2021 Sep; 31(11):634-650. PubMed ID: 33516611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E-Sexual Health: A Position Statement of the European Society for Sexual Medicine.
    Kirana PS; Gudeloglu A; Sansone A; Fode M; Reisman Y; Corona G; Burri A
    J Sex Med; 2020 Jul; 17(7):1246-1253. PubMed ID: 32340920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M
    Minerva Ginecol; 2015 Apr; 67(2):97-102. PubMed ID: 25763800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.
    Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M
    Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and long-term efficacy of fractional CO
    Behnia-Willison F; Sarraf S; Miller J; Mohamadi B; Care AS; Lam A; Willison N; Behnia L; Salvatore S
    Eur J Obstet Gynecol Reprod Biol; 2017 Jun; 213():39-44. PubMed ID: 28419911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lasers in Gynecology.
    Iglesia CB; Choi JE; Tadir Y
    Obstet Gynecol; 2024 Jun; ():. PubMed ID: 38843530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revitalizing research in genitourinary syndrome of menopause.
    Chang OH; Paraiso MFR
    Am J Obstet Gynecol; 2019 Mar; 220(3):246.e1-246.e4. PubMed ID: 30586548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What's New in Cosmetic Dermatology.
    Benedetto AV
    Dermatol Clin; 2019 Jan; 37(1):117-128. PubMed ID: 30466684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vulvar and vaginal fractional CO2 laser treatments for genitourinary syndrome of menopause.
    Streicher LF
    Menopause; 2018 May; 25(5):571-573. PubMed ID: 29406425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laser therapy for the genitourinary syndrome of menopause. A systematic review and meta-analysis.
    Pitsouni E; Grigoriadis T; Falagas ME; Salvatore S; Athanasiou S
    Maturitas; 2017 Sep; 103():78-88. PubMed ID: 28778337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.